Hostname: page-component-cb9f654ff-h4f6x Total loading time: 0 Render date: 2025-08-03T21:00:46.086Z Has data issue: false hasContentIssue false
  • English
  • Français

Is the Predisposition to Neuroleptic Malignant Syndrome Genetically Transmitted?

Published online by Cambridge University Press:  02 January 2018

Koichi Otani ,
Masayuki Horiuchi ,
Tsuyoshi Kondo ,
Sunao Kaneko  and
Yutaka Fukushima
Koichi Otani*
Affiliation:
Department of Neuropsychiatry, Hirosaki University Hospital, Hirosaki 036, Japan
Masayuki Horiuchi
Affiliation:
Hirosaki University Hospital
Tsuyoshi Kondo
Affiliation:
Hirosaki University Hospital
Sunao Kaneko
Affiliation:
Hirosaki University Hospital
Yutaka Fukushima
Affiliation:
Hirosaki University Hospital, Japan
*
∗ Correspondence
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 158 , Issue 6 , June 1991 , pp. 850 - 853
Copyright
Copyright © The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.Google Scholar
Bunney, W. E. J. & Garland, B. L. (1983) Possible receptor effects of chronic lithium administration. Neuropharmacology, 22, 367–372.CrossRefGoogle ScholarPubMed
Cohen, B. M., Baldessarini, R. J., Pope, H. G. J., et al (1985) Neuroleptic malignant syndrome. New England Journal of Medicine, 313, 1293.Google Scholar
Fricchione, G. L. (1985) Neuroleptic catatonia and its relationship to psychogenic catatonia. Biological Psychiatry, 20, 304–313.Google Scholar
Gelenberg, A. J. (1976) The catatonic syndrome. Lancet, i, 1339–1341.Google Scholar
Hermesh, H., Aizenberg, D., Lapidot, M., et al (1988) Risk of malignant hyperthermia among patients with neuroleptic malignant syndrome and their families. American Journal of Psychiatry, 145, 1431–1434.Google Scholar
Itoh, H., Ohtuska, N., Ogita, K., et al (1977) Malignant neuroleptic syndrome – its present status in Japan and clinical problems. Folia Psychiatrica et Neurologica Japonica, 31, 565–576.Google Scholar
Keck, P. E., Pope, H. G. & McElroy, S. L. (1987) Frequency and presentation of neuroleptic malignant syndrome: a prospective study. American Journal of Psychiatry, 144, 1344–1346.Google Scholar
Kellam, A. M. P. (1987) The neuroleptic malignant syndrome, so-called: a survey of world literature. British Journal of Psychiatry, 150, 752–759.Google Scholar
Lancet (1984) Neuroleptic malignant syndrome. Lancet, i, 545–546.Google Scholar
Nelson, T. E. & Flewellen, E. H. (1983) The malignant hyperthermia syndrome. New England Journal of Medicine, 309, 416–418.Google Scholar
Pope, H. G., Keck, P. E. & McElroy, S. L. (1986) Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. American Journal of Psychiatry, 143, 1227–1233.Google Scholar
Santos, J. L., Cabranes, J. A., Almoguera, I., et al (1989) Clinical implications of determination of plasma haloperidol levels. Acta Psychiatrica Scandinavica, 79, 348–354.Google Scholar
Spring, G. & Frankel, M. (1981) New data on lithium and haloperidol incompatibility. American Journal of Psychiatry, 138, 818–821.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.